GlycoMimetics, Inc.
HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3
Last updated:
Abstract:
Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin, galectin-3, or E-selectin and galectin-3 to ligands a disclosed. For example, heterobifunctional inhibitors of E-selectin and galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
28 Dec 2018
Issue date:
24 Dec 2020